Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare
Bio-Rad Laboratories Inc. Total Liabilities 2008–2025
Bio-Rad Laboratories Inc. annual/quarterly total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Bio-Rad Laboratories Inc. total liabilities for the quarter ending December 31, 2025 were 3.12B, a 11.74% increase year-over-year.
- Bio-Rad Laboratories Inc. total liabilities for 2025 were 3.12B, a 11.74% increase from 2024.
- Bio-Rad Laboratories Inc. total liabilities for 2024 were 2.79B, a 21.45% decrease from 2023.
- Bio-Rad Laboratories Inc. total liabilities for 2023 were 3.56B, a 8.45% decrease from 2022.
- Bio-Rad Laboratories Inc. total liabilities for 2022 were 3.89B.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Bio-Rad Laboratories Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $3,123 |
| 2024 | $2,795 |
| 2023 | $3,558 |
| 2022 | $3,886 |
| 2021 | $4,114 |
| 2020 | $3,093 |
| 2019 | $2,254 |
| 2018 | $1,591 |
| 2017 | $1,343 |
| 2016 | $1,271 |
| 2015 | $1,219 |
| 2014 | $1,156 |
| 2013 | $1,202 |
| 2012 | $1,428 |
| 2011 | $1,352 |
| Bio-Rad Laboratories Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $3,123 |
| 2024-12-31 | $2,795 |
| 2023-12-31 | $3,558 |
| 2022-12-31 | $3,886 |
| 2021-12-31 | $4,114 |
| 2020-12-31 | $3,093 |
| 2019-12-31 | $2,254 |
| 2018-12-31 | $1,591 |
| 2017-12-31 | $1,343 |
| 2016-12-31 | $1,271 |
| 2015-12-31 | $1,219 |
| 2014-12-31 | $1,156 |
| 2013-12-31 | $1,202 |
| 2012-12-31 | $1,428 |
| 2011-12-31 | $1,352 |
| 2010-12-31 | $1,522 |
| 2009-12-31 | $1,257 |
Bio-Rad Laboratories Inc. Total Liabilities — FAQ
Bio-Rad Laboratories Inc. (BIO) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIO's total liabilities history?
The chart and table above show Bio-Rad Laboratories Inc.'s total liabilities by year and by quarter, including the growth rate.